← Back to Search

High-Intensity Interval Nordic Walking for Coronary Artery Disease (HIIT-NoW Trial)

N/A
Recruiting
Led By Jennifer L Reed, PhD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to come onsite for exercise sessions
Patients with coronary artery disease treated with PCI or CABG
Must not have
Unstable angina or established diagnosis of atrial fibrillation, chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 11 follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a new exercise program that combines high-intensity interval training and Nordic walking can improve physical and mental health in patients with coronary artery disease.

Who is the study for?
This trial is for patients at least 40 years old with coronary artery disease who have had a stent inserted or heart bypass surgery. They must be willing to attend exercise sessions on-site, able to perform an exercise test measuring heart and lung function, and not currently in cardiac rehab.
What is being tested?
The study is testing if high-intensity interval Nordic walking can improve physical and mental health better than standard cardiovascular rehabilitation. It's a new way of exercising that works the whole body by using special poles while walking.
What are the potential side effects?
While specific side effects are not listed, high-intensity exercises may lead to muscle soreness, fatigue, increased heart rate during activity, and potential strain on the cardiovascular system especially in those with pre-existing conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to attend exercise sessions in person.
Select...
I have had heart artery treatment with stenting or bypass surgery.
Select...
I am 40 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have heart or severe lung conditions like unstable angina or COPD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 11 follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 11 follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Adverse events
Compliance
+3 more
Secondary study objectives
Blood pressure
Cardiorespiratory fitness
Depression
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-intensity interval Nordic walkingExperimental Treatment1 Intervention
Participants will receive high-intensity interval Nordic walking training.
Group II: ControlActive Control1 Intervention
Participants will undergo standard cardiovascular rehabilitation.

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
195 Previous Clinical Trials
93,460 Total Patients Enrolled
50 Trials studying Coronary Artery Disease
37,821 Patients Enrolled for Coronary Artery Disease
Jennifer L Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
6 Previous Clinical Trials
585 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
135 Patients Enrolled for Coronary Artery Disease

Media Library

High-intensity interval Nordic walking Clinical Trial Eligibility Overview. Trial Name: NCT05434117 — N/A
Coronary Artery Disease Research Study Groups: High-intensity interval Nordic walking, Control
Coronary Artery Disease Clinical Trial 2023: High-intensity interval Nordic walking Highlights & Side Effects. Trial Name: NCT05434117 — N/A
High-intensity interval Nordic walking 2023 Treatment Timeline for Medical Study. Trial Name: NCT05434117 — N/A
~16 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top